Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Other Accumulated Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Other Accumulated Expenses for 3 consecutive years, with $6.1 million as the latest value for Q1 2026.

  • Quarterly Other Accumulated Expenses rose 76.94% to $6.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Jan 2026, up 76.94% year-over-year, with the annual reading at $3.5 million for FY2025, 197.82% up from the prior year.
  • Other Accumulated Expenses for Q1 2026 was $6.1 million at Kestra Medical Technologies, up from $5.3 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $6.1 million in Q1 2026, with the low at $1.2 million in Q2 2024.
  • Average Other Accumulated Expenses over 3 years is $4.1 million, with a median of $4.3 million recorded in 2025.
  • The sharpest move saw Other Accumulated Expenses soared 197.82% in 2025, then soared 76.94% in 2026.
  • Over 3 years, Other Accumulated Expenses stood at $1.2 million in 2024, then skyrocketed by 348.87% to $5.3 million in 2025, then increased by 14.09% to $6.1 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $6.1 million, $5.3 million, and $5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.